Amanda Chu is a US Energy Reporter at the Financial Times. She covers a range of topics related to energy, including its intersection with business and economics, while also delving into themes such as public policy and government politics. Amanda's work has been featured in notable publications including Financial Times, Yahoo Finance, and POLITICO.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Amanda Chu's reporting focuses primarily on energy-related topics, with a strong emphasis on government announcements and legal policy regulations. She often includes data citations in her articles, suggesting an interest in fact-based and analytical content.
Given Amanda’s focus on energy and related government policies, she is likely to be responsive to pitches from experts who can provide insights into the impact of specific policies or regulatory changes within the energy sector. Pitches that offer unique perspectives or actionable solutions regarding clean energy, electric vehicles, climate change initiatives, and US-China relations may be particularly effective.
Amanda does not appear to have a specific geographic focus but seems to take an international view of issues concerning global power dynamics and their effects on the energy industry.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Amanda Chu
Calley Means said the health secretary and Trump are working in “lockstep.”
By: Amanda Chu
Amanda Chu Tue, April 21, 2026 at 8:27 PM GMT+2 3 min read
New disclosures show health industry firms and trade groups are spending more than ever to influence Washington.
The biggest players in the health care industry are pouring record sums into K Street as the Trump administration intensifies scrutiny of their business practices ahead of the midterms.
New disclosures show health industry firms and trade groups are spending more than ever to influence Washington.
Amanda Chu Fri, April 24, 2026 at 6:00 PM GMT+2 14 min read
Two of the most powerful lobbies in the country are turning on a third in the hopes of deflecting Washington’s wrath and securing bigger shares of the $5 trillion Americans spend on health care each year.
On right and left and among industry rivals, everyone is pointing the finger at the caregivers.
Manufacturers of ultraprocessed food are lobbying representatives to back a draft bill by Florida Republican Kat Cammack that would limit new regulations.
By: Caroline Hug, Amanda Chu
Washington is the pharmaceutical sector's closest ally in driving up drug prices in the EU, while attacking it back home.
